HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 35, Issue -, Pages 82-90
Publisher
Wiley
Online
2014-12-22
DOI
10.1111/liv.12735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
- (2014) Hyung Rae Sohn et al. BMC INFECTIOUS DISEASES
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
- (2014) Wai-Kay Seto et al. GUT
- The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment
- (2014) Chien-Hung Chen et al. JOURNAL OF HEPATOLOGY
- Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate
- (2014) Patrick Marcellin et al. JOURNAL OF HEPATOLOGY
- Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E
- (2014) Lucio Boglione et al. JOURNAL OF MEDICAL VIROLOGY
- Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B
- (2014) Min-Ran Li et al. PLoS One
- Optimization therapy for the treatment of chronic hepatitis B
- (2014) En-Qiang Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
- (2014) Gong-Ying Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Individualized treatment of HBeAg-negative CHB using peg-interferon alfa-2a as first-line and week 12 HBV-DNA\HBsAg stopping rule. A cost-effectiveness analysis
- (2013) Sergio Iannazzo et al. ANTIVIRAL THERAPY
- Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavir
- (2013) Robert G Gish et al. ANTIVIRAL THERAPY
- Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
- (2013) Dengming He et al. BMC INFECTIOUS DISEASES
- HBsAg Quantification to Predict Natural History and Treatment Outcome in Chronic Hepatitis B Patients
- (2013) Michelle Martinot-Peignoux et al. Clinics in Liver Disease
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
- (2013) Wai-Kay Seto et al. HEPATOLOGY
- Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels
- (2013) Milan J. Sonneveld et al. HEPATOLOGY
- Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel
- (2013) M. Chudy et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
- (2013) Tung-Hung Su et al. JOURNAL OF GASTROENTEROLOGY
- Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
- (2013) Maurizia R. Brunetto et al. JOURNAL OF HEPATOLOGY
- HBsAg quantification: useful for monitoring natural history and treatment outcome
- (2013) Michelle Martinot-Peignoux et al. LIVER INTERNATIONAL
- Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
- (2012) Patrick Marcellin et al. Hepatology International
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B
- (2012) Soon Sun Kim et al. HEPATOLOGY RESEARCH
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study
- (2012) Tetsuya Hosaka et al. JOURNAL OF GASTROENTEROLOGY
- Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
- (2012) Vincent Rijckborst et al. JOURNAL OF HEPATOLOGY
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
- (2012) Stéphane Chevaliez et al. JOURNAL OF HEPATOLOGY
- Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients
- (2012) Etsuro Orito WORLD JOURNAL OF GASTROENTEROLOGY
- Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
- (2011) Y. Liang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype
- (2011) Milan J Sonneveld et al. ANTIVIRAL THERAPY
- Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
- (2011) Henry L-Y Chan et al. ANTIVIRAL THERAPY
- Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir
- (2011) Jung Min Lee et al. HEPATOLOGY
- Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients
- (2011) Teerha Piratvisuth et al. Hepatology International
- Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
- (2011) Roeland Zoutendijk et al. JOURNAL OF INFECTIOUS DISEASES
- Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B
- (2011) Myoung Hee Lee et al. JOURNAL OF MEDICAL VIROLOGY
- Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B
- (2010) H. L.-Y. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
- (2010) Jurriën G.P. Reijnders et al. GASTROENTEROLOGY
- Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
- (2010) Gloria Woo et al. GASTROENTEROLOGY
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- Monitoring during and after antiviral therapy for hepatitis B
- (2010) Karin L. Andersson et al. HEPATOLOGY
- Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
- (2010) Vincent Rijckborst et al. HEPATOLOGY
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
- (2010) Karsten Wursthorn et al. HEPATOLOGY
- On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
- (2010) Wei Cai et al. JOURNAL OF CLINICAL VIROLOGY
- Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks
- (2010) Rami Moucari JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
- (2010) Jurriën G.P. Reijnders et al. JOURNAL OF HEPATOLOGY
- Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment
- (2010) Bettina E. Hansen et al. JOURNAL OF MEDICAL VIROLOGY
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
- (2009) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a
- (2009) Rami Moucari et al. ANTIVIRAL THERAPY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- On-treatment monitoring of HBV DNA levels: predicting response and resistance to oral antiviral therapy at week 24 versus week 48
- (2009) Ting-Tsung Chang Hepatology International
- Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B
- (2009) Pisit Tangkijvanich et al. JOURNAL OF CLINICAL VIROLOGY
- 917 ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
- (2009) G.K.K. Lau et al. JOURNAL OF HEPATOLOGY
- Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B
- (2009) Stefan Zeuzem et al. JOURNAL OF HEPATOLOGY
- High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
- (2009) Rami Moucari et al. JOURNAL OF HEPATOLOGY
- Monitoring drug therapy for hepatitis B—a global challenge?
- (2009) Tin Nguyen et al. Nature Reviews Gastroenterology & Hepatology
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
- (2008) Michael W. Fried et al. HEPATOLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation